METTL3 and urinary bladder cancer: Furthermore, in bladder cancer, gastric cancer, and colorectal cancer, increased expression of METTL3 correlated with poor prognosis (Han J. et al., 2019; Peng et al., 2019; Wang et al., 2020c).